Amyloidosis of the larynx mimicking a malignant neoplasm: report of a case associated with λ light chain restriction
Abstract
A 65 year old male presented at the ENT outpatients clinic with a two-month history of hoarseness. Laryngoscopic evaluation and CT imaging revealed submucosal mass involving the false vocal cords. A malignant neoplasm was suspected. Microscopic analysis revealed a hypocellular amorphous eosinophilic material diffusely deposited in the lamina propria. Congo red stain was consistent with amyloid deposition. The plasma cells within the deposition showed λ chain restriction. A diagnosis of laryngeal amyloidosis with λ light chain restriction was rendered. Follow-up of the patient showed no evidence of systemic involvement of a plasma cell neoplasm. Laryngeal amyloidosis is rare and may present clinically and radiographically as a malignant neoplasm. Light chain restriction of the associated plasma cells is usually seen. Controversy exists regarding the nature and pathogenesis of this disease entity.
Keywords
Full Text:
READ AS PDFReferences
Gouvêa AF, Ribeiro ACP, León JE, Carlos R, de Almeida OP, Lopes MA. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases. J Oral Pathol Med. 2012;41(2):178–85. Http://doi.wiley.com/10.1111/j.1600-0714.2011.01073.x
Ma L, Bandarchi B, Sasaki C, Levine S, Choi Y. Primary localized laryngeal amyloidosis: Report of 3 cases with long-term follow-up and review of the literature. Arch Pathol Lab Med. 2005;129(2):215–8.
Muchtar E, Buadi FK, Dispenzieri A, Gertz MA. Immunoglobulin light-chain amyloidosis: From basics to new developments in diagnosis, prognosis and therapy. Acta Haematol. 2016;135(3):172–90.
Rudy SF, Jeffery CC, Damrose EJ. Clinical characteristics of laryngeal versus nonlaryngeal amyloidosis. Laryngoscope. 2017;1–5. Http://doi.wiley.com/10.1002/lary.26846
Swan N, Skinner M, O’Hara CJ. Bone Marrow Core Biopsy Specimens in AL (Primary) Amyloidosis. Am J Clin Pathol. 2003;120(4):610–6. Https://academic.oup.com/ajcp/article-lookup/doi/10.1309/PFUGHBX0TY20E08U
Kourelis T V, Kyle RA, Dingli D, Buadi FK, Kumar SK, Gertz MA, et al. Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience. Mayo Clin Proc. 2017;92(6):908–17.
Http://www.ncbi.nlm.nih.gov/pubmed/28483059
Hazenberg AJC, Hazenberg BPC, Dikkers FG. Long-term follow-up after surgery in localized laryngeal amyloidosis. Eur Arch Oto-Rhino-Laryngology. 2016;273(9):2613–20.
Gallivan GJ, Gallivan HK. Laryngeal Amyloidosis Causing Hoarseness and Airway Obstruction. J Voice. 2010;24(2):235–9. Http://dx.doi.org/10.1016/j.jvoice.2008.07.006
Bartels H, Dikkers FG, van der Wal JE, Lokhorst HM, Hazenberg BPC. Laryngeal amyloidosis: localized versus systemic disease and update on diagnosis and therapy. Ann Otol Rhinol Laryngol. 2004;113(9):741–8.
Http://www.ncbi.nlm.nih.gov/pubmed/15453534
Lewis JE, Olsen KD, Kurtin PJ, Kyle RA. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg. 1992;106(4):372–7.
Http://www.ncbi.nlm.nih.gov/pubmed/1565488
Berg AM, Troxler RF, Grillone G, Kasznica J, Kane K, Cohen AS, et al. Localized amyloidosis of the larynx: evidence for light chain composition. Ann Otol Rhinol Laryngol. 1993;102(11):884–9. Http://www.ncbi.nlm.nih.gov/pubmed/8239352
Westermark P, Sletten K, Pitkänen P, Natvig JB, Lindholm CE. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL. Mol Immunol. 1982;19(3):447–50. Http://www.ncbi.nlm.nih.gov/pubmed/8239352
Refbacks
- There are currently no refbacks.
Copyright 2015-2017, Hellenic Society of Pathology
ISSN: 2459-3443